ELVN vs. VKTX

Last updated Jun 4, 2026

ELVN (Enliven Therapeutics Inc.) and VKTX (Viking Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, ELVN returned 2.00%/yr vs 41.01%/yr for VKTX. At a 0.31 correlation, their price movements are largely independent.

Performance

ELVN vs. VKTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enliven Therapeutics Inc. (ELVN) and Viking Therapeutics, Inc. (VKTX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ELVN achieves a 133.96% return, which is significantly higher than VKTX's -16.63% return.

ELVN

• 1D: 1.44%
• 1M: -13.41%
• YTD: 133.96%
• 6M: 71.57%
• 1Y: 64.82%
• 3Y*: 18.69%
• 5Y*: 2.00%
• 10Y*: —

VKTX

• 1D: 0.14%
• 1M: -7.65%
• YTD: -16.63%
• 6M: -17.17%
• 1Y: 10.22%
• 3Y*: 9.60%
• 5Y*: 41.01%
• 10Y*: 35.08%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ELVN vs. VKTX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
ELVN Enliven Therapeutics Inc.	133.96%	-31.56%	62.57%	-15.40%	81.78%	-89.80%	47.00%
VKTX Viking Therapeutics, Inc.	-16.63%	-12.57%	116.23%	97.98%	104.35%	-18.29%	37.65%

Correlation

The correlation between ELVN and VKTX is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.42
Correlation (3Y) Calculated over the trailing 3-year period	0.38
Correlation (5Y) Calculated over the trailing 5-year period	0.32
Correlation (All Time) Calculated using the full available price history since Mar 13, 2020	0.31

The correlation between ELVN and VKTX shifts across timeframes, from 0.31 (all time) to 0.42 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ELVN : $2.26B VKTX : $3.39B
EPS ELVN : -$1.69 VKTX : -$4.16
PB Ratio ELVN : 4.99 VKTX : 6.75
Total Revenue (TTM) ELVN : $0.00 VKTX : $0.00
Gross Profit (TTM) ELVN : -$46.00K VKTX : -$208.00K
EBITDA (TTM) ELVN : -$110.65M VKTX : -$501.77M

Return for Risk

ELVN vs. VKTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELVN

ELVN Risk / Return Rank: 71
ELVN Sharpe Ratio Rank: 67
ELVN Sortino Ratio Rank: 74
ELVN Omega Ratio Rank: 69
ELVN Calmar Ratio Rank: 72
ELVN Martin Ratio Rank: 74

VKTX

VKTX Risk / Return Rank: 47
VKTX Sharpe Ratio Rank: 46
VKTX Sortino Ratio Rank: 47
VKTX Omega Ratio Rank: 50
VKTX Calmar Ratio Rank: 46
VKTX Martin Ratio Rank: 46

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELVN vs. VKTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enliven Therapeutics Inc. (ELVN) and Viking Therapeutics, Inc. (VKTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ELVN	VKTX	Difference
Sharpe ratio Return per unit of total volatility	0.80	0.14	+0.66
Sortino ratio Return per unit of downside risk	1.94	0.72	+1.22
Omega ratio Gain probability vs. loss probability	1.22	1.11	+0.10
Calmar ratio Return relative to maximum drawdown	1.77	0.23	+1.54
Martin ratio Return relative to average drawdown	4.61	0.46	+4.15
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ELVN vs. VKTX - Sharpe Ratio Comparison

The current ELVN Sharpe Ratio is 0.80, which is higher than the VKTX Sharpe Ratio of 0.14. The chart below compares the historical Sharpe Ratios of ELVN and VKTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ELVN	VKTX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.80	0.14	+0.66
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.02	0.41	-0.38
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.36	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.09	0.11	-0.20

Drawdowns

ELVN vs. VKTX - Drawdown Comparison

The maximum ELVN drawdown since its inception was -98.20%, which is greater than VKTX's maximum drawdown of -90.41%. Use the drawdown chart below to compare losses from any high point for ELVN and VKTX.

Drawdown Indicators

	ELVN	VKTX	Difference
Max Drawdown Largest peak-to-trough decline	-98.20%	-90.41%	-7.79%
Max Drawdown (1Y) Largest decline over 1 year	-36.84%	-45.14%	+8.30%
Max Drawdown (3Y) Largest decline over 3 years	-56.05%	-78.86%	+22.81%
Max Drawdown (5Y) Largest decline over 5 years	-89.05%	-78.86%	-10.19%
Max Drawdown (10Y) Largest decline over 10 years	—	-89.26%	—
Current Drawdown Current decline from peak	-83.58%	-68.96%	-14.62%
Average Drawdown Average peak-to-trough decline	-84.22%	-60.01%	-24.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.09%	22.29%	-8.20%

Volatility

ELVN vs. VKTX - Volatility Comparison

Enliven Therapeutics Inc. (ELVN) has a higher volatility of 14.50% compared to Viking Therapeutics, Inc. (VKTX) at 13.65%. This indicates that ELVN's price experiences larger fluctuations and is considered to be riskier than VKTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ELVN	VKTX	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.50%	13.65%	+0.85%
Volatility (6M) Calculated over the trailing 6-month period	60.61%	41.31%	+19.30%
Volatility (1Y) Calculated over the trailing 1-year period	82.50%	73.85%	+8.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	85.81%	101.62%	-15.81%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	87.95%	97.09%	-9.14%

Dividends

ELVN vs. VKTX - Dividend Comparison

Neither ELVN nor VKTX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ELVN and VKTX in my portfolio?

ELVN and VKTX have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ELVN or VKTX?

ELVN has higher volatility (14.50%) compared to VKTX (13.65%). In terms of maximum drawdown, ELVN dropped -98.20% vs VKTX's -90.41%.

Which has better risk-adjusted returns?

ELVN currently has the higher Sharpe Ratio (0.80 vs 0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.